<p><strong>纽约，纽约 / ACCESS Newswire /2025 年 8 月 10 日/</strong> Levi &amp; Korsinsky 通知投资者，已对 Anika Therapeutics, Inc.（&#34;Anika Therapeutics, Inc.&#34;）展开调查，涉及可能违反联邦证券法的情况。</p>
<p>Anika 于 2025 年 7 月 30 日发布了一份新闻稿，&#34;宣布&#34;其在美国进行的 Hyalofast 临床试验的顶线结果，Hyalofast 是一种可被吸收的透明质酸支架，与自体骨髓抽取浓缩液（BMAC）结合用于软骨修复。&#34;新闻稿指出，&#34;虽然 Hyalofast 在所有疼痛和功能的评估指标上相较于微创手术显示出一致的改善，但该研究未能达到预先设定的共同主要终点。该研究可能受到微创手术组受试者更高的脱落率和 COVID 期间缺失的访视的影响。这导致数据缺失，减少了可评估样本量，并使统计分析变得复杂。&#34;</p>
<p>在此消息发布后，Anika 的股价在 2025 年 7 月 30 日下跌超过 27%。欲获取更多信息，请访问：</p>
<p>https://zlk.com/pslra-1/anika-therapeutics-inc-lawsuit-submission-form?prid=160674&amp;wire=1&amp;utm_campaign=50</p>
<p>或联系 Joseph E. Levi, Esq.</p>
<p><strong>为什么选择 LEVI &amp; KORSINSKY:</strong> 在过去 20 年中，Levi &amp; Korsinsky LLP 已建立为全国知名的证券诉讼公司，为受害股东争取了数亿美元，并在高风险案件中赢得了良好的记录。该公司在复杂证券诉讼中代表投资者方面拥有丰富的专业知识，并拥有超过 70 名员工为客户服务。连续七年，Levi &amp; Korsinsky 在 ISS Securities Class Action Services 的前 50 名报告中被评为美国顶级证券诉讼公司之一。律师广告。以往的结果并不保证类似的结果。</p>
<p><strong>联系方式：</strong></p>
<p>Levi &amp; Korsinsky, LLP</p>
<p>Joseph E. Levi, Esq.</p>
<p>Ed Korsinsky, Esq.</p>
<p><strong>来源：</strong> Levi &amp; Korsinsky, LLP</p>
<p>查看 ACCESS Newswire 上的原始新闻稿</p>

阿尼卡医疗

<p>Levi & Korsinsky 已对 Anika Therapeutics, Inc. 展开调查，原因是该公司在公布 Hyalofast 临床试验结果后可能违反了联邦证券法。尽管患者结果有所改善，但该试验未能达到其主要终点，导致 Anika 的股价在 2025 年 7 月 30 日下跌了 27%。此次调查旨在收集有关这些发展的更多信息</p>

<p><strong>NEW YORK, NY / ACCESS Newswire / August 10, 2025 /</strong> Levi &amp; Korsinsky notifies investors that it has commenced an investigation of Anika Therapeutics, Inc. (&#34;Anika Therapeutics, Inc.&#34;)  concerning possible violations of federal securities laws.</p>
<div class="lb-trans"><p><strong>纽约，纽约 / ACCESS Newswire /2025 年 8 月 10 日/</strong> Levi &amp; Korsinsky 通知投资者，已对 Anika Therapeutics, Inc.（&#34;Anika Therapeutics, Inc.&#34;）展开调查，涉及可能违反联邦证券法的情况。</p>
</div><p>Anika issued a press release on July 30, 2025, &#34;announc[ing] topline results from its U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair.&#34; The press release stated that &#34;[w] hile Hyalofast demonstrated consistent improvements in treated patients across all measures of pain and function relative to microfracture, the study did not meet its pre-specified co-primary endpoints. The study was likely impacted by both a higher subject dropout rate in the microfracture arm and missed visits during COVID. This resulted in missing data, which reduced the evaluable sample size and complicated the statistical analysis.&#34;</p>
<div class="lb-trans"><p>Anika 于 2025 年 7 月 30 日发布了一份新闻稿，&#34;宣布&#34;其在美国进行的 Hyalofast 临床试验的顶线结果，Hyalofast 是一种可被吸收的透明质酸支架，与自体骨髓抽取浓缩液（BMAC）结合用于软骨修复。&#34;新闻稿指出，&#34;虽然 Hyalofast 在所有疼痛和功能的评估指标上相较于微创手术显示出一致的改善，但该研究未能达到预先设定的共同主要终点。该研究可能受到微创手术组受试者更高的脱落率和 COVID 期间缺失的访视的影响。这导致数据缺失，减少了可评估样本量，并使统计分析变得复杂。&#34;</p>
</div><p>Following this news, Anika's stock price fell over 27% on July 30, 2025. To obtain additional information, go to:</p>
<div class="lb-trans"><p>在此消息发布后，Anika 的股价在 2025 年 7 月 30 日下跌超过 27%。欲获取更多信息，请访问：</p>
</div><p>https://zlk.com/pslra-1/anika-therapeutics-inc-lawsuit-submission-form?prid=160674&amp;wire=1&amp;utm_campaign=50</p>
<div class="lb-trans"><p>https://zlk.com/pslra-1/anika-therapeutics-inc-lawsuit-submission-form?prid=160674&amp;wire=1&amp;utm_campaign=50</p>
</div><p>or contact Joseph E. Levi, Esq.</p>
<div class="lb-trans"><p>或联系 Joseph E. Levi, Esq.</p>
</div><p><strong>WHY LEVI &amp; KORSINSKY:</strong> Over the past 20 years, Levi &amp; Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p><strong>为什么选择 LEVI &amp; KORSINSKY:</strong> 在过去 20 年中，Levi &amp; Korsinsky LLP 已建立为全国知名的证券诉讼公司，为受害股东争取了数亿美元，并在高风险案件中赢得了良好的记录。该公司在复杂证券诉讼中代表投资者方面拥有丰富的专业知识，并拥有超过 70 名员工为客户服务。连续七年，Levi &amp; Korsinsky 在 ISS Securities Class Action Services 的前 50 名报告中被评为美国顶级证券诉讼公司之一。律师广告。以往的结果并不保证类似的结果。</p>
</div><p><strong>CONTACT:</strong></p>
<div class="lb-trans"><p><strong>联系方式：</strong></p>
</div><p>Levi &amp; Korsinsky, LLP</p>
<div class="lb-trans"><p>Levi &amp; Korsinsky, LLP</p>
</div><p>Joseph E. Levi, Esq.</p>
<div class="lb-trans"><p>Joseph E. Levi, Esq.</p>
</div><p>Ed Korsinsky, Esq.</p>
<div class="lb-trans"><p>Ed Korsinsky, Esq.</p>
</div><p><strong>SOURCE:</strong> Levi &amp; Korsinsky, LLP</p>
<div class="lb-trans"><p><strong>来源：</strong> Levi &amp; Korsinsky, LLP</p>
</div><p>View the original press release on ACCESS Newswire</p>
<div class="lb-trans"><p>查看 ACCESS Newswire 上的原始新闻稿</p>
</div>

针对阿尼卡医疗公司（ANIK）的证券调查正在进行中 - 请联系 Levi & Korsinsky